CEA is one of the most useful tumor markers for carcinoma[24], and its expression was found to be correlated with clinicopathological features, such as venous involvement, greater diameter, and advanced stages of colorectal carcinomas[25,26]. This evidence concerns the gene CEACAM5 and colorectal carcinoma.